The syndicated platform for Advocacy Intelligence. ELAVAY measures how patient communities perceive your organization, showing where you lead, where gaps remain, and where to act. Benchmarking back to 2015 across 20+ disease states.
From cross-industry benchmarks to disease-specific deep dives, & fully custom studies built to answer your questions.
Your standing versus the industry on advocacy engagement, trust, and impact.
Granular insight within a specific condition and its community.
Where social drivers shape access, trust, and outcomes for patients.
How the patient voice is represented across the research enterprise.
Where policy pressure is moving and what advocates expect next.
Advocacy team scope, resourcing, and influence across biopharma.
A disciplined process protects data integrity, so findings hold up in front of leadership.
Define the topics and communities that matter most this cycle.
Invite-only fielding to verified advocacy organizations and leaders.
Qualitative depth that explains the "why" behind the numbers.
Data-integrity checks and weighting before anything ships.
ELAVAY is the research engine; Archo turns its findings into internal influence through advisory and training. The data tells you where to act. We help you act on it.
See Advisory & ActivationReal ELAVAY findings, from non-medical switching impact to copay-education gaps and literacy barriers, make the case better than any pitch. Explore a sample.
View sample intelligenceRequest an ELAVAY briefing and we'll show you what the patient community already knows about your organization.
